The FDA will replace the longstanding 21 CFR Part 820 Quality System Regulation (QSR) with the Quality Management System Regulation (QMSR) on February 2, 2026. This shift aligns U.S. medical device requirements with ISO 13485:2016, bringing the U.S. closer to global quality expectations.
Loading...
From 21 CFR 820 to QMSR: What Manufacturers Need to Know Before 2026
Loading...
“The final ruling is specifically calling for the 13485:2016 standard and essentially making this internationally recognized standard the backbone of FDA's quality system expectations,” explained Yuan Li, speaking at a 2025 webinar hosted by QMS software provider, Qualio. Yuan is Head of the North American Medical Team at DQS and ISO 13485/MDSAP lead auditor.
Loading...
What Will Change Under the New Regulation
Although the QMSR draws heavily from ISO 13485, extra FDA-specific requirements remain. The most notable are:
Expanded Inspection Scope
- Internal audits and management reviews are now part of FDA inspections.
- Contractors, relabelers, and foreign initial distributors are explicitly covered.
Control of Records (820.35)
- ISO’s recordkeeping rules are supplemented with U.S.-specific details.
- Complaint records must link to CAPAs and capture labeling or packaging failures.
Device Labeling and Packaging (820.45)
- FDA continues to require hands-on verification of labeling and storage, even if automated checks exist.
Systemic Risk Management
- Risk thinking now extends across the entire quality system, not just design controls.
- Alignment with ISO 14971 reduces the chance of late-stage issues or recalls.
Even a single missing signature or unlabeled record can slow an FDA inspection under the new QMSR.
Access Qualio’s tools
Access Qualio’s ISO 13485 Toolkit and get your quality score in minutes:
First Actions for Manufacturers
Yuan recommends starting with three straightforward steps:
- Conduct a gap analysis against ISO 13485:2016, with priority on design controls, complaint handling, and recordkeeping.
- Refresh documentation and terminology to reflect the the QMSR structure and expectations.
- Prepare teams for broader inspections, especially internal auditors and management review participants.
Have your team, especially your audit team, ready for the new inspection style.
“Even larger manufacturers can stumble if they leave documentation and complaint handling until the last minute,” noted Sumatha Kondabolu, a QA/RA specialist with two decades of experience in medical device quality systems, and Senior Quality Business Partner at Qualio.
“Building habits around signed, dated records and CAPA‑linked complaints early on makes the QMSR transition far less stressful.”
Loading...
Beyond Compliance: A Streamlined System
“Regulatory changes like the QMSR can seem overwhelming at first,” according to Sumatha’s extensive experience. “Breaking the transition into small, well‑defined tasks—like record control, complaint tracking, and CAPAs—helps teams stay on schedule and reduces last‑minute surprises.”
You can look at the QMSR as just a regulatory update, or an efficiency opportunity.
- Duplicate QSR and ISO documentation can be eliminated.
- Audit scheduling and preparation become simpler.
- Supplier and purchasing control will strengthen as partners align with ISO 13485.
Yuan sums it up: “Preparing for ISO 13485 is not just about surviving the 2026 transition—it’s about running a more efficient, globally credible quality system that supports growth.”
ISO 13485 is the Shortest Path to Readiness
“By getting the 13485 certificate, you already have your quality documentation largely aligned with QMSR expectations,” says Yuan. “There will still be some additional FDA-specific requirements and definitions, but that’s a small portion of the change you need to fine-tune.”
In short, companies already certified to ISO 13485 will face far fewer disruptions when QMSR takes effect.
Manufacturers who are certified will benefit in three practical ways:
- Reduced transition work: Most of the QMSR framework is already in place.
- Higher inspection credibility: “If you have an ISO 13485 certificate in front of an inspector, chances are they recognize that. It builds trust immediately,” Yuan notes.
- Potentially fewer FDA visits: Certification can influence inspection frequency under the FDA’s “least burdensome” approach, though it is not a substitute for full compliance.
With four decades of certification expertise, DQS provides internationally recognized ISO 13485 assessments that strengthen global credibility and prepare you for the upcoming QMSR requirements.
Contact us to discuss your certification options or request a non-binding quotation.
When you’re ready, reach out. DQS can provide ISO 13485 certification and objective assessment services to help you demonstrate readiness for QMSR.
Author
Yuan Li, PhD
Dr. Yuan Li holds a doctorate in Mechanical Engineering and has published 13 studies on spinal pathologies and implant innovation. He built his career in Regulatory Affairs, guiding 510(k) and CE certifications across the U.S., EU, and APAC regions. Since joining the notified body sector in 2015, he has advanced from orthopedic product reviewer to management, now overseeing North American operations with a focus on market growth and compliance.
Loading...
